On July 16th 2019, the LARISSA consortium officially started it's activities by means of a kick-off meeting in Lelystad, at the premises of Wageningen Bioveterinary Research. Representatives of CEPI were present as well.

In the LARISSA project, six consortium partners work with CEPI to develop and validate a novel vaccine against Rift Valley Fever. It is the first vaccine that potentially provides full protection with a single dose and has an optimal safety profile. 

Subscribe to Our Newsletter



© 2019 by BunyaVax BV.